Table 1.
Characteristics of the D-CarDia study cohorts, stratified by sex
| Sample size | Men
|
Women
|
All participants
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age (years) |
Systolic blood pressure (mm Hg) |
Diastolic blood pressure (mm Hg) |
Participants with hyper- tension |
Age (years) |
Systolic blood pressure (mm Hg) |
Diastolic blood pressure (mm Hg) |
Participants with hyper- tension |
Age (years) |
Systolic blood pressure (mm Hg) |
Diastolic blood pressure (mm Hg) |
Participants with hyper- tension |
||
| Studies in adults | |||||||||||||
| NFBC 1966 | 4488 (2270 men, 2218 women) | 31·2 (0·4) | 130·5 (13·2) | 80·4 (11·7) | 697 (31%) | 31·2 (0·3) | 120·5 (19·1) | 75·4 (10·7) | 280 (13%) | 31·2 (0·3) | 125·6 (13·9) | 77·9 (11·5) | 977 (22%) |
| Young Finns | 2443 (1123 men, 1320 women) | 37·6 (5·1) | 126·8 (14·2) | 79·5 (11·8) | 239 (21%) | 37·6 (5·0) | 117·6 (15·0) | 74·0 (11·8) | 167 (13%) | 37·6 (5·1) | 122·2 (14·6) | 76·8 (11·8) | 406 (17%) |
| NESDA | 1717 (551 men, 1166 women) | 43·7 (12·3) | 145·1 (19·5) | 85·1 (12·0) | 317 (58%) | 40·5 (12·7) | 130·6 (19·1) | 80·0 (11·6) | 336 (29%) | 41·5 (12·3) | 135·3 (19·2) | 81·6 (11·7) | 653 (38%) |
| 1958BC | 7152 (3525 men, 3627 women) | 45·0 (0·0) | 133·7 (15·6) | 82·6 (10·8) | 1229 (35%) | 45·0 (0·0) | 120·9 (16·1) | 75·9 (10·8) | 580 (16%) | 45·0 (0·0) | 127·2 (17·1) | 79·3 (11·3) | 1809 (25%) |
| GOYA | 1465 (1465 men, 0 women) | 45·6 (7·1) | 143·3 (19·3) | 93·4 (12·3) | 986 (67%) | ·· | ·· | ·· | ·· | 45·6 (7·1) | 143·3 (19·3) | 93·4 (12·3) | 986 (67%) |
| FHS | 5654 (2677 men, 2977 women) | 46·7 (12·9) | 125·7 (17·1) | 79·3 (10·4) | 582 (22%) | 46·2 (12·9) | 118·4 (19·6) | 73·7 (10·5) | 778 (26%) | 46·5 (12·9) | 122·1 (18·4) | 76·5 (10·5) | 1360 (24%) |
| LifeLines | 13 235 (5532 men, 7703 women) | 49·0 11·7) | 135·6 (16·1) | 79·7 (10·0) | 2186 (40%) | 48·5 (11·3) | 127·3 (18·0) | 74·8 (9·7) | 2089 (27%) | 48·7 (11·7) | 130·8 (17·2) | 76·8 (9·8) | 4275 (32%) |
| SPLIT | 498 (213 men, 285 women) | 47·9 (15·5) | 134·4 (18·9) | 80·9 (11·9) | 80 (38%) | 49·9 (13·9) | 127·9 (21·4) | 76·8 (12·5) | 92 (32%) | 49·1 (15·3) | 131·2 (20·1) | 78·9 (12·2) | 172 (35%) |
| Twins UK | 2392 (189 men, 2203 women) | 48·6 (12·4) | 130·2 (14·1) | 80·3 (9·9) | 53 (28%) | 49·1 (12·3) | 121·8 (16·0) | 76·8 (10·6) | 488 (22%) | 49·1 (12·4) | 122·6 (16·4) | 77·2 (10·8) | 541 (25%) |
| PREVEND | 3649 (1880 men, 1769 women) | 51·0 (13·0) | 136·0 (20·0) | 78·0 (11·0) | 732 (39%) | 48·0 (12·0) | 125·0 (22·0) | 72·0 (10·0) | 479 (27%) | 49·6 (12·9) | 130·6 (21·0) | 75·1 (10·5) | 1211 (33%) |
| DOPS | 1684 (0 men, 1684 women) | ·· | ·· | ·· | ·· | 50·1 (2·8) | 131·8 (20·6) | 83·0 (11·6) | 743 (44%) | 50·1 (2·8) | 131·8 (20·6) | 83·0 (11·6) | 743 (44%) |
| GENMETS | 868 (421 men, 447 women) | 49·2 (10·4) | 131·6 (18·8) | 83·2 (10·9) | 157 (37%) | 52·0 (11·6) | 130·8 (20·9) | 80·1 (11·1) | 163 (36%) | 50·7 (10·5) | 131·2 (19·9) | 81·6 (10·9) | 320 (37%) |
| DPP | 1998 (691 men, 1307 women) | 55·1 (10·9) | 129·7 (16·5) | 81·7 (11·0) | 264 (38%) | 50·4 (10·2) | 124·9 (16·8) | 78·8 (10·1) | 335 (26%) | 51·9 (10·9) | 126·5 (16·7) | 79·8 (10·4) | 599 (30%) |
| MRC NSHD | 2674 (1340 men, 1334 women) | 53·0 (0·0) | 141·8 (21·3) | 88·5 (13·1) | 767 (57%) | 53·0 (0·0) | 134·6 (21·5) | 832 (126) | 574 (43%) | 53·0 (0·0) | 138·2 (21·4) | 85·9 (12·9) | 1341 (50%) |
| ORCADES | 718 (334 men, 384 women) | 54·3 (15·7) | 137·5 (19·8) | 80·0 (10·7) | 145 (43%) | 53·0 (15·7) | 130·1 (22·8) | 77·1 (11·6) | 136 (35%) | 53·6 (15·7) | 133·8 (21·3) | 78·6 (11·2) | 281 (39%) |
| NPHSII | 2771 (2771 men, 0 women) | 56·1 (3·4) | 139·7 (20·5) | 85·4 (12·2) | 1460 (53%) | ·· | ·· | ·· | ·· | 56·1 (3·4) | 139·7 (20·5) | 85·4 (12·2) | 1460 (53%) |
| KORCULA | 901 (332 men, 569 women) | 57·5 (14·2) | 146·3 (22·1) | 86·3 (10·5) | 190 (57%) | 55·6 (13·7) | 140·6 (25·9) | 82·4 (11·8) | 274 (48%) | 56·3 (14·2) | 143·5 (24·0) | 84·3 (11·2) | 464 (52%) |
| VIS | 782 (323 men, 459 women) | 56·0 (15·0) | 141·6 (23·1) | 86·1 (14·2) | 152 (47%) | 57·1 (15·9) | 139·9 (27·9) | 83·0 (13·7) | 219 (48%) | 56·7 (15·1) | 140·8 (25·5) | 84·6 (13·9) | 371 (47%) |
| Tromsø | 9467 (4482 men, 4985 women) | 58·7 (13·1) | 146·4 (22·5) | 85·7 (13·5) | 2690 (60%) | 60·4 (14·1) | 147·7 (28·1) | 83·2 (15·2) | 2819 (57%) | 59·6 (13·7) | 147·1 (25·6) | 84·4 (14·5) | 5509 (58%) |
| Whitehall II | 5146 (3797 men, 1349 women) | 60·8 (5·9) | 132·6 (18·2) | 77·7 (11·6) | 1556 (48%) | 61·2 (6·1) | 130·7 (20·6) | 76·0 (12·1) | 578 (43%) | 60·9 (5·9) | 132·1 (18·8) | 77·2 (11·8) | 2134 (41%) |
| HBCS | 1728 (737 men, 991 women) | 61·4 (2·8) | 152·9 (22·2) | 94·8 (12·2) | 571 (77%) | 61·6 (3·1) | 149·6 (23·9) | 90·9 (12·1) | 713 (72%) | 61·5 (2·8) | 150·9 (23·2) | 92·5 (12·3) | 1284 (74%) |
| ESTHER | 8199 (4598 men, 3601 women) | 62·1 (6·7) | 139·4 (20·2) | 83·4 (10·2) | 2665 (58%) | 62·2 (6·5) | 140·9 (18·7) | 84·3 (10·4) | 2260 (63%) | 62·1 (6·6) | 140·0 (19·6) | 83·8 (10·3) | 4925 (60%) |
| LURIC | 3287 (2293 men, 994 women) | 61·2 (10·7) | 154·2 (23·9) | 90·4 (11·9) | 2146 (94%) | 64·8 (10·2) | 154·0 (25·9) | 88·0 (12·0) | 911 (92%) | 62·7 (10·7) | 154·2 (24·6) | 89·6 (11·9) | 3057 (93%) |
| EAS | 907 (448 men, 459 women) | 64·6 (5·6) | 141·7 (22·7) | 77·5 (11·4) | 222 (50%) | 64·2 (5·7) | 144·5 (24·4) | 76·9 (12·9) | 245 (53%) | 64·4 (5·6) | 143·1 (23·6) | 77·2 (12·2) | 467 (52%) |
| HCS | 2906 (1536 men, 1370 women) | 65·7 (2·9) | 139·5 (20·7) | 78·4 (11·7) | 855 (56%) | 66·7 (2·7) | 137·8 (22·7) | 69·7 (12·1) | 741 (54%) | 66·1 (2·9) | 138·7 (21·7) | 74·3 (12·6) | 1596 (55%) |
| ELSA | 5054 (2299 men, 2755 women) | 65·9 (9·4) | 138·0 (18·7) | 77·3 (11·8) | 1098 (48%) | 66·3 (9·8) | 136·6 (20·9) | 76·2 (11·3) | 1261 (46%) | 66·1 (9·4) | 137·2 (19·9) | 76·7 (11·5) | 2359 (47%) |
| InCHIANTI | 1210 (540 men, 670 women) | 67·2 (15·4) | 149·6 (21·8) | 86·4 (10·0) | 400 (74%) | 69·1 (15·6) | 153·2 (26·6) | 86·6 (11·8) | 485 (72%) | 68·3 (15·4) | 151·6 (24·4) | 86·5 (11·0) | 885 (73%) |
| PIVUS | 995 (498 men, 497 women) | 70·1 (0·2) | 150·7 (25·4) | 82·5 (12·2) | 347 (70%) | 70·2 (0·2) | 157·7 (26·1) | 81·0 (12·2) | 366 (74%) | 70·2 (0·2) | 154·2 (25·9) | 81·8 (12·2) | 713 (72%) |
| ULSAM | 1129 (1129 men, 0 women) | 71·0 (0·64) | 150·8 (21·9) | 86·4 (11·7) | 790 (70%) | ·· | ·· | ·· | ·· | 71·0 (0·64) | 150·8 (21·9) | 86·4 (11·7) | 790 (70%) |
| Health ABC | 1554 (826 men, 728 women) | 74·9 (2·9) | 137·6 (21·3) | 74·7 (12·0) | 528 (64%) | 74·7 (2·8) | 141·6 (23·7) | 73·4 (12·6) | 474 (65%) | 74·8 (2·9) | 139·6 (22·5) | 74·0 (12·3) | 1002 (64%) |
| MrOS Sweden | 2911 (2911 men, 0 women) | 75·4 (3·2) | 155·2 (23·9) | 83·0 (12·1) | 1355 (47%) | ·· | ·· | ·· | ·· | 75·4 (3·2) | 155·2 (23·9) | 83·0 (12·1) | 1335 (47%) |
| Studies in adolescents | |||||||||||||
| LISAplus and GINIplus | 901 (480 men, 421 women) | 10·2 (0·2) | 108·5 (9·8) | 61·9 (8·1) | ·· | 10·2 (0·2) | 108·8 (9·8) | 63·2 (8·5) | ·· | 10·2 (0·2) | 108·6 (9·8) | 62·5 (8·3) | ·· |
| NFBC 1986 | 5460 (2769 men, 2691 women) | 16·0 (0·0) | 121·1 (12·3) | 68·6 (7·9) | ·· | 16·0 (0·0) | 110·2 (10·7) | 66·9 (7·2) | ·· | 16·0 (0·0) | 115·6 (11·5) | 67·8 (7·6) | ·· |
| TRAILS | 1289 (619 men, 670 women) | 16·2 (0·06) | 122·1 (12·3) | 60·3 (6·9) | 54 (9%) | 16·2 (0·7) | 114·5 (11·2) | 61·7 (6·8) | 17 (3%) | 16·2 (0·08) | 118·1 (11·7) | 61·0 (6·8) | 71 (6%) |
| GOOD | 941 (941 men, 0 women) | 18·9 (0·6) | 130·7 (13·3) | 68·4 (7·9) | 240 (26%) | ·· | ·· | ·· | ·· | 18·9 (0·6) | 130·7 (13·3) | 68·4 (7·9) | 240 (26%) |
Data are n, mean (SD), or n (%).